methylprednisolone has been researched along with Autoimmune Pancreatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hori, Y; Ikeura, T; Ito, T; Masuda, M; Mitsuyama, T; Naganuma, M; Nakamaru, K; Nakayama, S; Okazaki, K; Shimatani, M; Sumimoto, K; Takaoka, M; Takaori, A; Tomiyama, T; Tsukuda, S; Uchida, K | 1 |
| Akashi, T; Ashida, K; Demiya, M; Fukami, K; Ito, H; Kubo, S; Motomura, S; Nagayama, A; Nomura, M; Ueda, U | 1 |
2 other study(ies) available for methylprednisolone and Autoimmune Pancreatitis
| Article | Year |
|---|---|
Long-term Outcomes after Steroid Pulse Therapy in Patients with Type 1 Autoimmune Pancreatitis.
Topics: Autoimmune Pancreatitis; Humans; Methylprednisolone; Prednisolone; Recurrence; Retrospective Studies; Steroids; Treatment Outcome | 2023 |
IgG4-Related Membranous Nephropathy with Acute Nephrotic Syndrome During Successful Steroid Maintenance Treatment for Type 1 Autoimmune Pancreatitis.
Topics: Acute Disease; Autoimmune Pancreatitis; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunoglobulin G4-Related Disease; Insulin; Male; Methylprednisolone; Nephrotic Syndrome; Proteinuria; Steroids | 2023 |